ENTITY

Jiangsu Hengrui Pharmaceuticals (1276 HK)

316
Analysis
Health Care • China
Jiangsu Hengrui Pharmaceuticals is a global biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of innovative and high-quality drugs. The company focuses on therapeutic areas including oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. It was founded in 1970 and is headquartered in Lianyungang, Jiangsu, China.
more
•26 Jan 2026 15:21

Eastroc Beverage A/H Listing - Good Quality but Tight Pricing

Eastroc Beverage Group (605499 CH) (EB), a China-based functional beverage company, aims to raise around US$1.3bn in its H-share listing. In this...

Logo
307 Views
Share
•25 Jan 2026 10:15

A-H Premium Weekly (Jan 23rd): Chifeng Jilong Gold Mining, Flat Glass, Maanshan Iron & Steel

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Chifeng Jilong Gold Mining, Flat Glass, Maanshan Iron &...

Logo
281 Views
Share
•22 Jan 2026 10:00

HK A+H IPO 2025: Essential Statistics Ahead of the 2026 Wave

A+H IPOs in 2025: with the A–H premium compression, why did some IPOs still work while most large deals failed to deliver excess returns?

Logo
556 Views
Share
bullish•Muyuan Foods Co
•20 Jan 2026 13:41

Muyuan Foods A/H Listing - PHIP Updates and Thoughts on A/H Premium

Muyuan Foodstuff Co Ltd A (002714 CH), a leader in the hog farming industry, aims to raise around US$1.5bn in its H-share listing. In this note, we...

Logo
337 Views
Share
bullish•Muyuan Foods Co
•19 Jan 2026 13:33

Muyuan Foods A/H Listing - Long Term Growth with Short-Term Volatility

Muyuan Foodstuff Co Ltd A (002714 CH), a leader in the hog farming industry, now aims to raise around US$1.5bn in its H-share listing. We had...

Logo
886 Views
Share
x